Skip to main content
52°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Biora Therapeutics, Inc.
< Previous
1
2
Next >
Biora Therapeutics Announces New Patent for its NaviCap™ Targeted Oral Delivery Platform
December 19, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors
December 18, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform
December 11, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
November 30, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Third Quarter 2023 Financial Results and Provide Corporate Update
November 06, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Submits Updated IND Application for BT-600
October 30, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Submit Updated IND Application for BT-600
October 23, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
October 05, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Submission of IND Application to the U.S. FDA for BT-600 Program
September 25, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Reduces Debt and Largest Shareholder Increases Equity Exposure
September 19, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 11, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Progresses its BioJet™ Systemic Oral Delivery Platform
September 05, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 14, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Patents Covering its BioJet™ Systemic Oral Delivery Platform
August 03, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Clinical Device Performance Study Results for its NaviCap™ Targeted Oral Delivery Platform
July 27, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update
July 17, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets
July 05, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces New Patents for its NaviCap™ Targeted Oral Delivery Platform
June 28, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific Sessions
June 26, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 13, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Present Preclinical Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of Diabetes
June 08, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 15, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update
May 08, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Appoints Dr. Ariella Kelman as Chief Medical Officer
May 01, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Participate in Crohn’s & Colitis Foundation’s IBD Innovate Conference
April 20, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
March 30, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
March 23, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor Agonist
February 23, 2023
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
BIOR
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.